Results from phase1b APD334 for autoimmune diseases released
Results from phase1b APD334 for autoimmune diseases released
Arena Pharmaceuticals, Inc. released the first results from its phase 1b trial that for the evaluation of an oral drug candidate called APD334 for the treatment of autoimmune diseases, such as multiple sclerosis (MS). The multiple ascending dose clinical trial demonstrated encouraging findings about the drug, which is designed to target the sphingosine 1-phosphate subtype 1 (S1P1) receptor............ Read More - http://www.ms-uk.org/emergingtherapies
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 7 Replies
- 2287 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1236 Views
-
Last post by frodo
-
- 0 Replies
- 1555 Views
-
Last post by frodo
-
- 0 Replies
- 1587 Views
-
Last post by frodo
-
- 0 Replies
- 1768 Views
-
Last post by Tif
-
- 0 Replies
- 1349 Views
-
Last post by Tif
-
- 1 Replies
- 1140 Views
-
Last post by Scott1
-
- 1 Replies
- 1668 Views
-
Last post by frodo